| http://www.w3.org/ns/prov#value | - While the EMA is generally more lenient than the FDA, especially on the efficacy side, the EMA can be more sensitive to potential side effects, since it does not have as robust of a surveillance of post-marketing problems as the FDA does in the United States.
|
